A much-needed shot in the arm for HIV vaccine development
International efforts towards developing avaccine against HIV infection have been given a much-needed boost bythe publication today of the Global HIV/AIDS Vaccine Enterprise'sscientific strategic plan, published online in the freely available,open-access global health journal PLoS Medicine.The Global HIV/AIDS Vaccine Enterprise is an international alliance ofindependent agencies and organiz...Clam embryo study shows pollutant mixture adversely affects nerve cell development
A scientist at the Marine BiologicalLaboratory (MBL) has published the results of an EPA-funded clam embryostudy that supports her hypothesis that, when combined, the pollutantsbromoform, chloroform, and tetrachloroethylene--a chemical cocktailknown as BCE--can act synergistically to alter a key regulator in nervecell development. While scientists have previously studied the effectsof these...Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
It's all in the packaging. How nature wraps and tags genes determines if and when they become active, according to researchers from Harvard and the Massachusetts Institute of Technology (M.I.T.). They did the largest, most detailed study to date of the protein structure that surrounds the human genome. Their findings reveal surprising and previously unknown specifics of how genes get switc...Scientists develop new color-coded test for protein folding
Every protein--from albumin to testosterone --is folded into a unique, three-dimensional shape that allows it to function properly. Now Stanford University scientists have developed a simple test that instantly changes color when a protein molecule attached to a gold nanoparticle folds or unfolds. The new technique, which works on the sa...Hybridoma Development from QED Bioscience Inc.
Description:QED Bioscience has over 23 years of experience in the development of hybridoma cells lines. We have made antibodies to large and small peptides, proteins, haptens, carbohydrates, bacterial and viral antigens, and plasmid DNA-encoded antigens. We understand and appreciate that every antigen is unique, so our hybridoma development programs are never "cookbook". We will tailor a program to your need...Equine TNF alpha ELISA development Kit, Screening Set from Endogen
Description:Endogens Screening Sets contain the basic components and protocol required to develop five colorimetric sandwich ELISA plates for quantitation of a specific protein in 100 l/well of cell culture supernate. Every Screening Set contains Coating and Detection Antibodies, Recombinant Standard (5 individual standards), Streptavidin-HRP, TMB Substrate Solution (one-step) and Stop Solution. Each standar...Canine IL-10 ELISpot Development Kit from R&D Systems
Description:Request Info...RNArticles: RNA Amplification Used to Develop a New In Vitro HCMV Assay
Gene arrays can be used to simultaneously measure the expression levels of thousands of genes in a single experiment. One limitation of this technology is that large amounts of RNA may be required for each array hybridization experiment -- typically 10 g of total RNA. This becomes problematic when working with limited sampl...Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.
Recent advances in combinatorial chemistry and genomics programs have led to an unprecedented increase in both the number of compounds and potential drug targets that can be screened. The development of automated liquid h...Who owns software developed for your company?
Even when there is a written contract, the specifics of ownership of the intellectual property in the software are often no...Evolutionary developmental biology
in an attempt to determine the ancestral re...Developmental, neurologic problems common in extremely preterm infants
Extremely preterm infants born before 25 weeks' gestation often have severe neurologic and developmental disabilities, researchers report in the August 10th issue of The New EnglandJournal of Medicine.The EPICure Study Group identified 308 children born at the gestational age of 25 weeks or earlier in the UK and Ireland. Of these, 283 were assessed for neurologic function Based on their l...Cancer drugs in development nearly doubled since 1995
The number of drugs being developed for the treatment of cancer has nearlydoubled during the past six years, according to a new survey of pharmaceuticalcompanies.Currently, 170 pharmaceutical and biotechnology firms various CancerInstitutes are investigating 402 compounds for the treatment of variouscancers, up from 215 in 1995. Many of the drugs are alternatives to standardradiatio...Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
A NOVEL research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, and an Indian company for the development of a potential AIDS vaccine to halt the spread of the deadly disease in the country is in an advanced stage of finalisation. Two Hyderabad-based biotechnology/pharma companies -- Shanta Biotechnics and Biological E -- are reportedly the front-runners f...New antibiotic already developing resistance
An anti biotic, just a year old, which was developed to fight resistant bacteria, is already becoming stale as the bacteria are showing signs of resistance. The drug linezolid is used to treat Enterococcus faecium (E. faecium) infections that are resistant to the old standby antibiotic vancomycin. The hope has been that the new drug would help tackle the growing problem of vancomycin-res...Velo Auto 8500 Motorized Refractor
Description:Already, the most advanced motor driven refractor, the VELO 8500 Motorized Refractor is easier and faster to learn and operate. Specialized features significantly reduce refraction time while maintaining accuracy and precision. Our software makes operating the VELO 8500 Motorized Refractor an easy transition from manual instruments or other automated units. In fact, the operator's control panel g...Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Recent clinical studies support the development of DG041 as aneffective anti-platelet that does not increase bleeding risk REYKJAVIK, Iceland, June 25, 2007 /PRNewswire-FirstCall/ --deCODE genetics today announced progress in the development ofDG041, the company's Phase II developmental compound for theprevention of arterial thrombosis. The results of the Phase IIa andclinical pharmacolog...Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
ALAMEDA, Calif.--(BUSINESS WIRE)--Jun 21, 2007 - Advanced CellTechnology, Inc. (OTCBB: ACTC) has successfully produced a humanembryonic stem cell (hESC) line without destroying an embryo at itslab in Worcester, Massachusetts. This development was announced byRobert Lanza, M.D., V.P. of Research and Scientific Development ofAdvanced Cell Technology (ACT) on Tuesday at the fifth annualmeeting...